The current valuation score of Kura Oncology Inc is 6.73, ranking 298 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.09, which is -21.38% below the recent high of -2.43 and -264.93% above the recent low of -11.29.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.